UBI Pharma Inc.

UBI Pharma was established on July 31, 2014 as a spin-off company from United Biomedical, Inc., Asia. UBI Pharma specializes in developing and manufacturing innovative protein drugs and formulations of small molecule pharmaceuticals.
UBI Pharma is dedicated to developing innovative protein drugs and specialty injectables on exclusively owned long-acting protein drug platforms, such as fusion proteoglycan, fusion single Fc chain, and new formulations. UBI Pharma has the US FDA approved sterile injectables filling line. These patented platforms, in combination with our manufacturing experience and the clinical resources in Taiwan, are paving the way for UBI Pharma’s success in the global market.

◆ Biosimilars / Innovative Protein Drugs
  ✧ UB-851 Erythropoietin (EPO)
  ✧ UB-852 Innovative EPO
  ✧ UB-854 Factor IX
  ✧ UB-551 Innovative IFNα8
  ✧ UB-853 Innovative GCSF

◆ Innovative Small Molecular Drug
  ✧ UB-941 B-RAF Kinase Inhibitor

◆ Specialty Injectables
  ✧ MD19 Central Insipidus
  ✧ MD20 Anti-fungal
  ✧ MD21 Prostate Cancer Endometriosis
  ✧ MD22 Anti-fungal
  ✧ MD23 Acromegaly
  ✧ MD25 Antipsychotic
  ✧ MD26 Diabetes
  ✧ MD27 Antipsychotic

◆ Contract Development and Manufacturing Organization (CDMO) / Contract Research Organization (CRO)

UNION BIOMEDICAL TECH. CO., LTD.

Superclean Low Temperature Medical Washer/Disinfector、Superclean disinfectants、J5090 Skin and Wound Cleanser.
Unionscope Low Temperature Disinfection Tech. research team is advised by Nobel Laureate. The new cleaning, disinfection and sterilization all-in-1 automatic machine (U.S.PATENT 5087374 & ROCPAT-I 284543) combines Ultrasound, UV, Ozone, and Sterilants (Superclean) used in cleaning of all kinds of medical devices. It combines and shortens existing complex steps of washing, manual cleaning, decontamination, disinfection, and sterilization process all in just one simple step. It combines Superclean, a revolution technology of medical disinfectant used in surgical equipment, cardiac catheterization and clinic equipment for disinfection and sterilization. Dr. Ding leads the team in conducting multiple research and experiments to be applied in many different fields including environmental disinfection, sterilization, skin protection, oral protection, feminine use protection, pet’s protection and medical sterilization areas. It helps people to prevent them from getting infected by bacteria and viruses. Our biotechnology is already certified by TFDA, National Taiwan University Hospital (NTUH), China Medical University (CMU), Taipei City Fire Department (TCFD) and many medical units. In 2015, we received the innovation of the Year Award, also, received YuShan National Quality Award in 2016.

Unison Healthcare Group

Medical Imaging & Robotic Surgery：
1. da Vinci Surgical System
2. MAKO Robotic Arm Interactive Orthopedic System
3. EOS 3D low dose imaging system
4. ROSA robotic surgical system
5. InTouch RP System
* Integrate medical related services for emerging market

Unison Healthcare Group (UHG), an ISO9001 and ISO13485 certified medical solution integrator in Asia, exist to fulfill our vision to deliver cutting edge medical technologies, devices, and healthcare systems to the world where everyone can reach and afford.

At the expo, we will be introducing Medical Imaging & Robotic Surgery such as da Vinci Surgical System, MAKO Robotic Arm Interactive Orthopedic System, EOS 3D low dose imaging system, ROSA robotic surgical system and InTouch Remote Presence System.

With more than 60 years in the market and providing services to more than 45 countries, we select and deliver tailor-made solutions and services to our clients around the world, integrate medical related services for emerging market. UHG continues to expand into other domains in the healthcare industry and to contribute our professional and capabilities to enhance the quality of medical services. We seek to invite new cooperation opportunities and furthering international partnerships to join us on our caring path as “We Care About Life”!

United Biomedical, Inc., Asia.

As a science-driven pharmaceutical industry pioneer in Taiwan, UBI Asia is dedicated to developing treatments, prophylactics, and diagnostics products with our in-house technologies.
By applying UBI’s proprietary UBITh^® designer vaccine technology, UBI Asia and UBI are co-developing innovative synthetic peptide vaccines. Anti-IgE allergy vaccine and anti-IL6 vaccine for autoimmune diseases are our leading human vaccine products with high market potential. In terms of animal vaccine, foot-and-mouth disease virus vaccine (FMDV vaccine), immunocastration vaccine for swines (LHRH vaccine), porcine reproductive and respiratory syndrome vaccine (PRRS vaccine) are just some examples of our complete pipeline. FMDV vaccine was approved for marketing in China in 2007 as a type I new drug for animals. Currently, our FMDV vaccine has a market share of 30% in China and has sold over 3 billion doses. In addition, LHRH vaccine has been approved for marketing in Mexico and Taiwan.

◆ Technology Platform
  ✧ UBITh^® Technology
  ✧ Lipoprotein Vaccine
  ✧ Adenovector-based Vaccine
◆ Products 　
  ✧ Human Vaccine：
     • Anti-IgE Vaccine
     • Anti-IL6 Vaccine
     • HPV Vaccine
     • Acinetobacter baumannii Vaccine
     • HFMD Vaccine
  ✧ Animal Vaccine：
     • PRRS Vaccine
     • IL-31 Vaccine
     • FMDV Vaccine
     • LHRH Vaccine
  ✧ Snake Venom Antiserum
     • Lyophilized Antivenom

United BioPharma, Inc

United BioPharma (UBP) was established in September 2013 as a spinoff company from UBI Asia, taking UBI Asia's entire monoclonal antibody (mAb) pharmaceutical business, including product rights, technologies, R&D teams, and manufacturing facilities.
UBP focuses on developing, manufacturing, and marketing integrated therapeutic mAb products and related technologies.


◆ Innovative biologics:
✧ UB-421: Anti-CD4 Antibody for HIV
✧ UB-621: Anti-HSV gD Antibody for HSV
✧ UB-221: Anti-IgE antibody for Asthma
✧ UB-923: Anti-CD20 Antibody for Non-Hodgkin’s Lymphoma
✧ UB-925: Anti-VEGFR2 for Multiple Cancers
✧ UB-926: Anti-Her2 for Breast Cancer

◆ Contract Development and Manufacturing Organization (CDMO)

United Neuroscience, Inc.

UNS is pioneering a novel UBITh immunotherapeutic vaccine for neurodegenerative diseases and neuro-disorders. Through developing innovative therapies that recognize and target multiple misfolded proteins, UNS aim to make a meaningful impact on the lives of patients affected by neurodegenerative diseases caused by protein misfolding and the families who care for them day after day. UNS' UB-311 is a first-in-human amyloid-beta peptide vaccine which is shaped by an experienced team with profound experiences in neurodegeneration, drug development and prolific collaboration world-wide. UB-311 is a safe and well-tolerated vaccine and potential in improving cognition in patients, currently enrolled in a phase-II trial, with mild Alzheimer's dementia.

United Orthopedic Corp.

Universal Eye Center Group

Universal Eye Center Group
Universal Eye Center
Universal Vision started off as a professional ophthalmologic medical profession but later on developed into a multi-business that covers glasses chain stores, laser vision corrections, medical beauty, and products. A life-long health care system was established to render sustainable services.
Surgery Service
1.Femtosecond Lasik for Myopia
2.Femtosecond Lasik for Presbyopia
3.Cataract Surgery
4.Femtosecond laser-assisted cataract surgery
5.Eye Check
6.OK Lens
7.Ophthalmologist Lecture
8.Medical Consultation
9.Routine Eye Diseases Check